Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Elisa L. J. Moya"'
Autor:
Elisa L. J. Moya, Elodie Vandenhaute, Eleonora Rizzi, Marie-Christine Boucau, Johan Hachani, Nathalie Maubon, Fabien Gosselet, Marie-Pierre Dehouck
Publikováno v:
Pharmaceutics, Vol 13, Iss 6, p 892 (2021)
Central nervous system (CNS) diseases are one of the top causes of death worldwide. As there is a difficulty of drug penetration into the brain due to the blood–brain barrier (BBB), many CNS drugs treatments fail in clinical trials. Hence, there is
Externí odkaz:
https://doaj.org/article/5b225005fd8b4e4dae47da0fba591632
Autor:
María Ángel García, Alberto Mesa, Elisa L. J. Moya, Igor Zwir, Luis Javier Martinez-Gonzalez, Gabriel Lopez-Ordoño, María Belén Ortega-García, Eduardo Redondo-Cerezo, Javier Ángel García, Juan A. Marchal, Macarena Perán, Javier Luis Lopez-Hidalgo, V. Conde, Gema Jiménez, Coral del Val, Beatriz Rueda
Publikováno v:
Cancers
Volume 12
Issue 2
Cancers, Vol 12, Iss 2, p 379 (2020)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Volume 12
Issue 2
Cancers, Vol 12, Iss 2, p 379 (2020)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Colorectal cancer treatment has advanced over the past decade. The drug 5-fluorouracil is still used with a wide percentage of patients who do not respond. Therefore, a challenge is the identification of predictive biomarkers. The protein kinase R (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96ca1fa23bb9066e4cc8c9e2e62c57bb
Autor:
Elodie Vandenhaute, Marie-Pierre Dehouck, Johan Hachani, Fabien Gosselet, Nathalie Maubon, Marie-Christine Boucau, Eleonora Rizzi, Elisa L J Moya
Publikováno v:
Pharmaceutics
Pharmaceutics, MDPI, 2021, 13 (6), pp.892. ⟨10.3390/pharmaceutics13060892⟩
Pharmaceutics, Vol 13, Iss 892, p 892 (2021)
Volume 13
Issue 6
Pharmaceutics, MDPI, 2021, 13 (6), pp.892. ⟨10.3390/pharmaceutics13060892⟩
Pharmaceutics, Vol 13, Iss 892, p 892 (2021)
Volume 13
Issue 6
International audience; Central nervous system (CNS) diseases are one of the top causes of death worldwide. As there is a difficulty of drug penetration into the brain due to the blood–brain barrier (BBB), many CNS drugs treatments fail in clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aaff6dd9a1823f4ee52933db04d9068
https://doi.org/10.3390/pharmaceutics13060892
https://doi.org/10.3390/pharmaceutics13060892
Autor:
Daniel Erskine, Mary Johnson, Johannes Attems, Carmen Martin-Ruiz, Sean J. Colloby, John-Paul Taylor, Alan J. Thomas, Sophie Graham, Madhurima Dey, Charles De Carli, Ian G. McKeith, Elisa L. J. Moya, Lauren Walker, Kirsty E. McAleese
Publikováno v:
Acta Neuropathologica
The research was supported by the Alzheimer’s Society (Grant Number: AS-PG-2013-011). Tissue for this study was provided by the Newcastle Brain Tissue Resource, which is funded in part by a grant from the UK Medical Research Council (G0400074) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e13a2fb73f85f73bb1c53849b2f8c6ce
https://doi.org/10.1007/s00401-017-1738-2
https://doi.org/10.1007/s00401-017-1738-2
Autor:
Johannes Attems, Kirsty E. McAleese, Sean J. Colloby, Sophie Graham, Elisa L. J. Moya, Ian G. McKeith, John-Paul Taylor, Madhurima Dey, Lauren Walker, Mary Ann Johnson, Daniel Erskine, Alan J. Thomas, Charles DeCarli
Publikováno v:
Alzheimer's & Dementia. 13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fcb3d42c85f59787794e505fb8194dd
https://doi.org/10.1016/j.jalz.2017.06.1635
https://doi.org/10.1016/j.jalz.2017.06.1635